Kolexia
Ziol Marianne Anatomie et cytologie
Ziol Marianne
Anatomie et cytologie
Hôpital Avicenne
Bobigny, France
135 Activités
3 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome hépatocellulaire Carcinomes Tumeurs du foie Fibrose Cirrhose du foie Maladies du foie Hépatite Stéatose hépatique Hépatite C

Collaborateurs

Voir plus
Carrie Nathalie
Carrie Nathalie
Hôpital Jean Verdier, Bondy, France
Nault Jean-Charles
Nault Jean-Charles
Hôpital Jean Verdier, Bondy, France
Nahon Pierre
Nahon Pierre
Hôpital Jean Verdier, Bondy, France
Seror Olivier
Seror Olivier
Hôpital Jean Verdier, Bondy, France

Industries

Voir plus
MSD
2 collaboration(s)
Dernière en 2023
Roche
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver international : official journal of the International Association for the Study of the Liver   04 mars 2024
Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: A multicentric retrospective study.
United European gastroenterology journal   07 décembre 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
The Lancet. Oncology   08 novembre 2023
Dynamic evolution of circulating tumor DNA in patients with hepatocellular carcinoma across tumor stages and treatments
Abstracts of the A.I.S.F. - Italian Association for the Study of the Liver Monothematic Conference “Liver oncology: from basic science to liver transplantation" Padua, September 28th-29th, 2023   01 septembre 2023
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
Journal of hepatology   28 août 2023
Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis.
Journal of hepatology   09 juin 2023
Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment.
Experimental hematology & oncology   15 mai 2023
Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma.
Journal of hepatocellular carcinoma   28 décembre 2022
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis.
Journal of hepatology   22 novembre 2022
Plasma Metabolomic and Lipidomic Profiling of Metabolic Dysfunction-Associated Fatty Liver Disease in Humans Using an Untargeted Multiplatform Approach.
Metabolites   08 novembre 2022